Asensus Surgical Inc (AMEX:ASXC)
$ 0.3479 0 (0%) Market Cap: 94.92 Mil Enterprise Value: 107.57 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 16/100

TransEnterix, Inc. - Special Call Transcript

Dec 06, 2019 / 04:00PM GMT
Release Date Price: $2.33 (-4.90%)
Anthony Fernando
TransEnterix, Inc. - President, CEO & Director

Good morning, and welcome to the Transenterix Surgeon Panel Discussion & New Technology Demonstration. I'm Anthony Fernando, TransEnterix' President and CEO.

As a reminder, today's event is being recorded and will be available at the Investor Relations section of our website.

During today's event, we may be making some forward-looking statements regarding our business, or statements about the development of our technology. I'll pause here for just a moment to allow you to review our forward-looking statements.

Let's get started.

Thanks again for joining us this morning. The focus of today's event is to provide insights into real-world application of Senhance and provide additional details around our technology pipeline as well as provide the opportunity to have both company and surgeon panel address specific questions.

We recognize that potential customers and investors have heard about the technology and the market directly from us multiple times, and we wanted to take this

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot